The National Association of Insurance Commissioners and industry stakeholders are updating the association's model law on drug formularies for the first time since 2003, hoping to modernize it for a new era that includes the Affordable Care Act and Medicare Part D. While the nation's top prescription drug lobby and consumer advocates are pleased that commissioners want to revisit the model and see it as an opportunity to apply consumer protections from Medicare and the ACA across the board, pharmacy...